Objective To evaluate the targeted therapeutic efficiency of 131I-Herceptin on human ovarian carcinoma with high expression of HER-2/neu in vivo and in vitro.Methods There were five groups in the experiment, including ...

Cervical cancer is one of the most common malignant tumours. The morbility and mortality are in the first place of malignant tumours in female. Owing to the cytology screening, the morbility and mortality have decreased ...

The HER2/neu proto-oncogene （also known as c-ErbB2, neu, and HER2） encodes a 185-kDa transmembrane glycoprotein with intrinsic tyrosine kinase activity that resembles the receptor for epidermal growth factor.

Study confirms the long-term benefit of trastuzumab (Herceptin) for women with early breast cancer. February 5th, 2012 . Posted in healthcareComments Off. Women with an aggressive type of early stage as trastuzumab for one year following ...

Objectives:1. To study the influence of the different combination schedule with paclitaxel and 5-FU on the proliferation of Her2-positive and Her2-negative gastric cancer cell lines in vitro,and to determine the optimal ...

They released him to a nursing home yesterday and now I am here getting Herceptin so this is my eighth day in a row visiting Littleton Hospital. I think that dementia is far worse than cancer and that visiting him right now is ...

On January 16, 2012 Bloomberg News published an article on trastuzumab (Herceptin) and lapatinib (Tykerb) combined treatment for Human Epidermal Growth Factor Receptor 2 (HER2)-positive early breast cancer. This phase 3 study, ...

Genentech, Dako Submit Applications to FDA for Herceptin in HER2-Positive Stomach Cancer. June 2, 2010 / Pharmacogenomics Reporter · Absent 'Gold Standard' for HER2 Testing, Researchers Question Role of Oncotype ...

Using gene chips to profile tumors before therapy, scientists at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary therapy for HER2-positive breast cancer.